© Copyright 2026, All Rights Reserved
Microcycle® platform for intracellular drug discovery
Screen for biologically active hits in live mammalian cells; Discover cyclic peptides for intracellular targets; Develop first-in-class small molecules for cancer therapy; Identify therapeutic candidates for immunology and inflammation; Enable hit-to-lead programmes for novel disease targets
Featured on Biotech TV in July 2025; Co-Founder Ali Tavassoli featured on Optimum Perspectives podcast in June 2025; Focus on first-in-class drugs for intracellular targets